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ABSTRACT 
Good and quality social support has been positively associated with mental health and 
researchers and clinicians are increasingly recognising the important protective role it plays 
in people living with HIV/AIDS (PLWA).  
We investigated whether the mental health (depression) of patients receiving antiretroviral 
treatment (ART) in a public-sector treatment programme in the rural district of 
Umkhanyakude, KwaZulu-Natal, South Africa is influenced by social support and 
strategies to cope with HIV infection.  Depression was assessed in a cross-section of 272 
patients (mean age 38 years, age range 20-67 years) with the General Health Questionnaire 
12 (GHQ12).  A GHQ12 score of 4 or higher indicated mental health pathology 
(depression), while lower scores indicated normal mental health.   
We regressed depression on sex, age, marital status, education, household wealth, social 
support (instrumental and emotional social support), and 6 strategies to cope with HIV 
infection.  Holding the other variables constant, “instrumental social support” was a 
significant predictor of mental health pathology (OR = 0.65 P<0.001, 95% CI 0.52 - 0.81).  
Using “avoidance of people” as a strategy to cope with HIV increased the odds of 
depression almost threefold (OR = 2.79 P=0.006, 95% CI 1.34 - 5.82), “trying to keep it 
from bothering” one reduced it by a factor two (OR = 0.45 P=0.068, 95% CI 0.20 - 1.06).  
33% of patients were depressed indicating that depression is very common in patients on 
ART in rural South Africa.  In addition to drug treatment, interventions improving 
instrumental social support and changes in the strategies to cope with HIV infection may be 
effective in reducing this disease burden among ART patients. 
v 
 
ACKNOWLEDGEMENT  
First, I am extremely thankful to God whose infinite grace and wisdom guided me 
throughout the studies, and my sponsor, INDEPTH NETWORK for the fellowship award 
that enabled me pursue this course. Secondly, I would like to express my deepest thanks to 
Professor Kerstin Klipstein-Grobusch and all the staff of the School of Public Health, 
University of Witwatersrand and Professor Till Barnighausen of the Africa Centre for 
Health and Population Studies and Harvard School of Public Health for their enormous 
supervision and guidance throughout this research.   
I would like to express my profound gratitude to the Director and entire staff of Africa, 
Centre South Africa for their reception, providing me with the data which serves as the 
basis for this report and creating conducive learning environment that enabled me to write 
this report. Also, I am grateful to the director and staff of Navrongo Health Research Centre 
for giving me the opportunity to pursue this course here in South Africa. 
Also, my gratitude goes to Rev and Mrs Eastwood Anaba (senior pastorate - FGC, 
Bolgatanga Ghana), Rev Stephen Koomson, and Rev and Mrs Eric Afrifa and the entire 
membership of FGC, Navrongo for their prayers and support throughout my studies. To Ps 
Themba Manana, my brother and friend in South Africa and entire membership of Let’s Go 
to Glory Worship Centre (LGTG), Johannesburg South Africa I express my heartfelt 
felicitations. And to Pastors Simon Wekoli, Stephen Apotara, Roland Owusu Ansah, James 
Brownson, and all my friends (Charles Annan, Cudjoe Armstrong Portia, Seraphin, Marcus 
Sellase, Lius Yaw Afful  etc) and my entire colleague at Wits, God richly bless you.  
vi 
 
TABLE OF CONTENTS 
DECLARATION ................................................................................................................................. ii 
DEDICATION .................................................................................................................................... iii 
ABSTRACT ........................................................................................................................................ iv 
ACKNOWLEDGEMENT ................................................................................................................... v 
TABLE OF CONTENTS ..................................................................................................................... v 
DEFINITION OF TERMS .................................................................................................................. ix 
LIST OF ACRONYMS AND ABBREVIATIONS ............................................................................. x 
LIST OF TABLES .............................................................................................................................. xi 
LIST OF FIGURES ........................................................................................................................... xii 
LIST OF APPENDICES ................................................................................................................... xiii 
CHAPTER ONE ................................................................................................................................. 1 
1.0 INTRODUCTION AND LITERATURE REVIEW ................................................................. 1 
1.1 Background Information ....................................................................................................... 1 
1.2 Problem Statement ................................................................................................................ 3 
1.3 Justification for the study ...................................................................................................... 4 
1.4 Literature Review .................................................................................................................. 5 
1.5 STUDY OBJECTIVES ......................................................................................................... 9 
1.5.1 Main Objective ............................................................................................................... 9 
1.5.2 Specific objectives ......................................................................................................... 9 
CHAPTER TWO .............................................................................................................................. 10 
2.0 METHODOLOGY .................................................................................................................. 10 
2.1 Introduction ......................................................................................................................... 10 
2.2 Study Area ........................................................................................................................... 10 
2.3 Study Design ....................................................................................................................... 11 
vii 
 
2.4 Study Population and Sample Size ..................................................................................... 11 
2.4.1 Sampling ...................................................................................................................... 12 
2.4.2 Inclusion criteria........................................................................................................... 12 
2.4.3 Exclusion criteria ......................................................................................................... 12 
2.5   Data Sources ..................................................................................................................... 12 
2.6 Data Collection.................................................................................................................... 14 
2.7 Description and Measurement of Study Variables .............................................................. 14 
2.7.1 Explanatory variables ................................................................................................... 14 
2.7.2 Other explanatory variables ......................................................................................... 17 
2.7.3 Outcome variable ......................................................................................................... 17 
2.8 Data Management ............................................................................................................... 17 
2.9 Data Analysis ...................................................................................................................... 18 
2.9.1 Descriptive analysis ..................................................................................................... 18 
2.9.2 Inferential Statistics ...................................................................................................... 18 
2.10 Ethical Considerations ...................................................................................................... 19 
2.11 Dissemination of Results................................................................................................... 19 
CHAPTER THREE ........................................................................................................................... 20 
3.0 RESULTS ............................................................................................................................... 20 
3.1 Introduction ......................................................................................................................... 20 
3.2 Patients Characteristics ....................................................................................................... 21 
3.3 Prevalence of depression in HIV patients on ART ............................................................. 22 
3.4 Social Support ..................................................................................................................... 25 
3.5 Strategies to cope with HIV/AIDS ...................................................................................... 25 
3.6 Socio-Economic Status (SES) ............................................................................................. 26 
3.7 CD4 cell count .................................................................................................................... 26 
viii 
 
3.8 Socio-demographic factors .................................................................................................. 27 
CHAPTER FOUR ............................................................................................................................. 30 
4.0 DISCUSSION AND CONCLUSION ..................................................................................... 30 
4.1 Discussion ........................................................................................................................... 30 
4.1.1 Social Support and outcome of depression .................................................................. 33 
4.1.2 Coping strategies HIV infection and the outcome of depression ................................. 36 
4.1.3 Socio-economic status (SES) and depressive outcome ................................................ 38 
4.1.4 CD4 cell count and the outcome of depression ............................................................ 39 
4.2 Implications and Recommendations ................................................................................... 40 
4.3 Methodological Considerations .......................................................................................... 42 
4.3.1 Limitations of study ..................................................................................................... 42 
4.3.2 Strengths of the study ................................................................................................... 42 
4.4 Conclusions ......................................................................................................................... 43 
REFERENCES.................................................................................................................................. 45 
 
 
 
 
 
ix 
 
DEFINITION OF TERMS 
1. Depression: refers to an illness that involves the body, mood, and thoughts.  It 
affects the way a person thinks and sleep, the way one feels about oneself, and the 
way one thinks about things (NIMH: AJP  2002)  Depression was measured using 
the General Health questionnaire 12 (GHQ12) and any participants (patients) who 
had a score of four (4) or more on the GHQ12 scoring method was considered to 
have symptoms of depression.  
2. Social support: This refers to the emotional, informational, or instrumental 
assistance from others (Dunkel-Schetter & Bennett, 1990) 
3. Instrumental social support: refers to tangible services that patients receive from 
network members such as, get help when sick, get financial assistance, 
transportation, advice about problems  
4. Emotional social support: given assurance or goodwill from network members to 
patients such as love and affection 
5. Coping strategies: refers to the specific behavioural and psychological efforts that 
people employ to master, tolerate, reduce, or minimize stressful events (Lazarus & 
Launier, 1978). 
6. Socio-economic status: Proxy measure of the wealth of households which is based 
on household   characteristics, ownership of assets (telephone cell phone, watch, 
radio\stereo, electric stove plate, gas cooker, Fridge television set, video cassette 
recorder, car/bakkie, motorcycle/scooter, bicycle, sofa, bed nets, cattle etc.)                       
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CHAPTER ONE 
1.0 INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Background Information 
HIV/AIDS is one of the most pressing health problems the World is faced with in our time. The 
global burden of HIV/AIDS is enormous, especially in developing countries. Sub-Saharan Africa 
(SSA) remains the most affected region with more than two thirds (68%) of people living with 
HIV/AIDS (PLWHA) and more than three quarters (76%) of all AIDS deaths in 2007.(1) 
According to the UNAIDS, 1.7 million people were infected with HIV/AIDS in 2007 bringing to 
22.5 million the total number of people living with the virus. Southern Africa accounts for 35% of 
all people living with HIV (the largest number of HIV infections in the world.) and almost one 
third of all new HIV infections and AIDS deaths globally in 2007.(1) In South Africa data indicates 
29% HIV/AIDS prevalence among pregnant women and 18.8% among adults population (15-49 
years) and about 12% among the general population in 2005.(2, 3, 105) 
Since the launch of WHO’s ‘3 by 5’ initiative in 2003 (an initiative to put at least 3 million 
HIV/AIDS patients on antiretroviral treatment by the year 2005), many countries in SSA have 
established national antiretroviral treatment (ART) programmes. By the end of 2005, an estimated 
1.3 million people in low- and middle-income countries had access to treatment, about 20% of 
those estimated 5-6 million currently in need of ART, including 4 million persons in Africa.(3)  A 
significant numbers of infected people develop mental health problems, and this often adversely 
impacts on HIV/AIDS treatment and adherence.(9) Integrating psychiatric and psychosocial 
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interventions  could benefit both the mental and the physical health of people living with 
HIV/AIDS.(4) 
The expansion of AIDS treatment initiatives in resource poor settings provides an opportunity for 
integrating mental health care into HIV treatment. The WHO recommends that attention to the 
psychosocial needs of PLWHA should be an integral part of HIV care.(5) Typically, the 
psychological issues associated with HIV illness evolve for individuals and families over the 
dynamic course of HIV illness and vary depending on the stage of the illness.(6, 7) The introduction 
of ART has seen a shift in emphasis from coping with the disease to living with and managing 
HIV as a chronic health condition. This, however, has not eliminated the psychological impact of 
infection. Coping with the uncertainty of future health and HIV stigma remain the most difficult 
psychological challenges that permeate many facets of life, even in the context of optimal access 
to ART.(8)  
In July 2004, a group of mental health professionals at a meeting in Johannesburg, South Africa, 
under the auspices of the WHO recommended that mental health be integrated into the ‘3 by 5’ 
initiative to support the programme’s goals and the need to support research on mental health and 
HIV/AIDS.(9) Although, over 90% of the burden of HIV/AIDS is in developing countries, little 
research has been conducted in these countries on HIV and mental health. Whereas mental health 
care has been integrated into HIV programs in developed countries for many years as a result of 
substantial evidence of linkages between HIV/AIDS and mental health,(10, 11) this has not been the 
case in developing countries, thus, the need to replicate this in SSA in general and South Africa in 
particular.  
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In 2003, population-based HIV testing was started in the Africa Centre Demographic Information 
System (ACDIS) through annual surveys for all resident men age 15-54 years; all resident women 
age 15-49 years, as well as 12.5% of non-residents of these ages.(12) This survey was the first of its 
kind in South Africa to investigate HIV/AIDS prevalence in a rural setting among residents and 
non-residents. This was complemented by an ART roll out program in 2004. However, the 
provision of ART without accompanying mental health and other psychosocial services will most 
likely not produce the true and lasting beneficial impact.(4) It is thus important to find ways to 
provide and sustain these necessary services for individuals and families in SSA with limited 
mental health infrastructure. This study aims to determine the mental health status of HIV patients 
who were accessing antiretroviral treatment (ART) at the KwaMsane clinic in the Hlabisa ART 
rollout programme in Kwazulu-Natal between 7th November 2007 and 6th December 2008.   
 
1.2 Problem Statement 
Since the introduction of ART programs in South Africa in 2004, more HIV/AIDS patients are 
now accessing care and treatment. Although, the ART initiation has redirected more focus from 
coping with the disease to living with and managing HIV/AIDS as a chronic health condition, the 
psychological impact of infection still remains. Coping with the uncertainty of future health and 
HIV/AIDS stigma remain the most difficult psychological challenges that HIV/AIDS positive 
individuals are still grappling with. Studies in Europe and North America have shown that 
significant number of infected people develops mental health problems including depression and 
anxiety, and this often adversely impacts on HIV/AIDS treatment and adherence. Although, a 
number of HIV/AIDS patients who are on ART have developed mental disorders, no study has 
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been carried out to examine the predictors of mental health disorders in HIV/AIDS patients on the 
ART rollout programs in rural South Africa. 
1.3 Justification for the study 
As the ART roll-out extends in developing countries, psychological factors such as stigma, 
disclosure, and self-efficacy and economic factors will have particular relevance for the success of 
these programs. Studies in developed countries revealed that HIV-positive individuals often suffer 
from depression and anxiety disorders as they adjust to the diagnosis, adapt to life with a chronic, 
life-threatening illness, anticipate and receive news of the disease’s progression and witness the 
death of friends and family members.(13-18) The literature demonstrates that mental health 
morbidity is associated with poor ART adherence and that mental health care has been integrated 
into HIV/AIDS programs in developed countries for many years as a result of linkages between 
mental health and HIV/AIDS. The WHO Mental Health working group has recommended that not 
only should mental health be an integral part of ART roll out programs in developing countries, 
but also that mental health and HIV/AIDS research be given priority support if the programs are to 
succeed. 
Although a few studies have been done on the population prevalence of mental illness in Africa in 
general and South Africa in particular, no study has explored the link between HIV/AIDS and 
mental illness (depression) in the KwaZulu-Natal (KZN) province, which has the highest 
HIV/AIDS infection in South Africa.  The few studies that looked at mental health and HIV/AID 
were done in Gauteng and Western Cape provinces that could not be generalised to KZN.  Thus, 
research will be crucial to inform the integration of metal health into the ART roll out programs 
and provision of HIV/AIDS care services. This research seeks to fill this gap by identifying the 
factors that affect mental health status (depression) of HIV patients on an ART roll out programme 
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in KwaZulu-Natal, South Africa. Findings from this research will add to the body of knowledge on 
the link between HIV/AIDS and mental health.  
1.4 Literature Review 
The Global Burden of Disease Survey estimates that by the year 2020, mental illness and 
HIV/AIDS will both be in the top 10 causes of morbidity in developing countries.(19) Since the 
beginning of the HIV epidemic, people living with HIV/AIDS have faced numerous psychological 
and behavioural challenges. The advent of antiretroviral therapy (ART) has drastically shifted 
from some of these key challenges and brought to the forefront new ones, prominent among which 
is mental health.(8) 
 Research from Europe and North America has suggested that HIV may affect mental health in 
different ways over time. Early in the course of HIV disease, the psychosocial impact of an HIV 
diagnosis, a universally fatal and often stigmatized disease, presents a significant stressor that may 
increase the prevalence of mental disorders.(13, 14) Several studies have suggested that depressive 
and anxiety disorders may speed the progression of HIV disease.(15, 16) Evidence from literature 
also suggests mental illnesses may increase high-risk behaviours for the further transmission of 
HIV.(17, 18) Although, there are few data on the population prevalence of mental illness in African 
countries, estimates from the World Mental Health Survey suggest that the burden of mental 
illnesses may be substantial, particularly common mental disorders of depression, post-traumatic 
stress disorder, and substance abuse.(20)  
According to Bing and colleagues, 36% and 16% prevalence of depression and anxiety 
respectively was found among a large national sample of HIV-positive persons in the United 
States.(7) A meta-analysis of studies comparing HIV-positive and HIV-negative samples showed 
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that major depressive disorder occurred nearly twice as often among HIV-positive than HIV-
negative patients.(21)  Other studies have shown that adults and children living with HIV/AIDS 
and/or at risk of acquiring HIV/AIDS are at an elevated risk of psychosocial distress and 
psychiatric conditions, particularly depression.(22-24) 
Some studies for instance, found that intermittent depressive symptoms in HIV positive women 
are associated with disease progression, lower CD4 cell counts, and higher baseline viral load 
levels; and, in general, women with chronic depression have mortality rates twice as high as those 
with little or no depressive symptoms.(25, 26)  
Evidence from a number of studies indicates that mental disorders are a significant impediment to 
adherence to antiretroviral therapy.(27, 28) For instance, a recent study in Peru suggests that in 
addition to the treatment of specific mental disorders, several behavioural interventions derived 
from mental health practice may also contribute to adherence.(29)  Another study in America 
suggests that depression can reduce the motivation to seek health care, impair adherence to 
treatment, and increase mortality.(25) 
Cook  and colleagues have found that high levels of depressive symptoms and poor mental health 
significantly reduced utilization of Highly Active Antiretroviral Therapy (HAART) among a 
cohort of HIV seropositive women in the USA.(30) Their findings are supported by other studies 
which indicate that depression is one of the factors that are often linked to poor ART adherence.(31, 
32)
 Similar results were found by Olley and colleagues in a study of psychosocial determinants of 
HIV-related quality of life among HIV-positive patients among the military in Nigeria.(33) 
Tegger and colleagues in a study in an urban clinic setting found that mental illness and substance 
use disorders were common among HIV-infected patients.(34) Their findings are consistent with 
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studies conducted on HAART that showed a delay in initiation of antiretroviral medications 
among patients with mental illness.(35, 36)  One study found that patients with mental illness were 
less likely to receive antiretroviral medications.(37) Also, a study of outpatients’ clinic population 
in Australia by Peter and Sternhell using General Health Questionnaire (GHQ) found a significant 
association between psychiatric morbidity and poor medication adherence.(38)  
Despite the importance of HIV/AIDS and mental health because of their substantial contribution to 
the burden of disease, literature indicates that only a handful of studies have examined the 
interactions between the epidemic of HIV/AIDS infection and mental illness in SSA. Collins and 
his colleagues(39) who did a systematic review of literature on HIV and mental illness in 
developing countries, examined mental health risk factors and consequences for HIV, 
psychosocial interventions of relevance for HIV persons, and their relevance for HIV care and 
treatment programs. Among the articles reviewed 30 studies described the mental health 
consequences of HIV infection; and two reports described psychosocial interventions. Increased 
physical symptoms of HIV were related to poorer quality of life and greater anxiety.(37) The review 
demonstrates the need for sound studies of mental health throughout the course of HIV, including 
factors that support good mental health and interventions that employ identified variables (e.g. 
family support) for efficacy in reducing symptoms of mental illness. 
Although South Africa has a high prevalence of both mental disorders and HIV infection, little is 
known about the occurrence of mental health illness among HIV-infected persons in general and 
those on ART in particular.(40-42)   In a cross-sectional study among individuals enrolled into HIV 
care and treatment services near Cape Town, South Africa, Myer and colleagues(43) demonstrated 
high prevalence (19%) levels of depression among HIV-infected persons. However this prevalence 
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is lower than levels found in smaller studies of HIV-infected individuals in South Africa, Tanzania 
and developed country settings.(44-46)   
In a study of 149 individuals diagnosed with HIV in South Africa, Olley and colleagues found 
substantial prevalence of both major depression (35%) and post-traumatic stress disorder (15%) 
among them.(43, 47, 48) While this study suggests that the burden of mental illness among HIV-
infected individuals may be considerable, further research is clearly needed to establish the 
distribution and determinants of psychopathology among HIV-infected individuals in different 
settings as well as the mechanisms through which HIV influences mental health status. Freemen 
and colleagues(49) who studied factors associated with prevalence of mental disorder in people 
living with HIV/AIDS in South Africa found  43.7% prevalence of mental disorder among 
participants with depression being the most common disorder (11% major and 29% minor 
depression). Similarly, Nair and Pillay found 33% prevalence of depressive disorders among 
patients in a South African general hospital.(50)    
Nachega and colleagues in a study on ART adherence in HIV-infected adults in Soweto, South 
Africa found the fear of being stigmatized by sexual partners to be independently associated with 
lower adherence.(51) 
Evidence from the literature above strongly suggests that several studies that have been done in 
Europe and North America (developed countries) indicated an association between mental health 
and HIV/AIDS, which has led to the integration of mental health care into HIV programs.(4, 13-18, 20-
23) However, the situation is completely different in SSA where the burden of HIV/AIDS is much 
felt. Although  health professionals, who attended a meeting organised by WHO in South Africa in 
2004 recommended mental health should be integrated into the ART roll out programs in SSA and 
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support be given to research on mental health and HIV/AIDS, the literature indicates that only a 
handful of studies have examined the interactions between HIV/AIDS and mental illness.  This 
study addresses in part this gap by examining mental health data collected on HIV patients on a 
rural ART roll out program in Kwazulu-Natal, South Africa in 2008.  
 
1.5 STUDY OBJECTIVES 
1.5.1 Main Objective 
The main objective of this study is to examine associates of mental health status of HIV patients  
enrolled in Africa Centre Demographic Surveillance Area (AC DSA) ART rollout programme in 
KwaZulu-Natal, South Africa between 7th November 2007 and 6th February 2008.  
1.5.2 Specific objectives 
1. To measure depression prevalence in HIV/AIDS patients on ART in a public-sector ART 
programme in rural South Africa 
2. To examine whether social support and coping strategies affect the outcome of depression 
in HIV/AIDS patients on ART in rural South Africa 
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CHAPTER TWO 
2.0 METHODOLOGY 
 
 2.1 Introduction 
This chapter covers the background information about the study area, study design and sampling 
methods. Data sources, a detail description of the GHQ12 used to measure depression, data 
collection methods, measurements of study variables and data analysis are also covered in this 
chapter.  
2.2 Study Area  
The Africa Centre Demographic Information Systems (ACDIS) is a longitudinal Demographic 
Surveillance System (DSS), which is situated in the municipalities of Hlabisa and Mtubatuba, in 
the Umkhanyakude District of Northern Kwazulu Natal, South Africa. The ACDIS maps 10,000 
inhabited homesteads in a 438km2 area, following a total population of approximately 85 000 
people who are members of about 11,000 households. Information on births, deaths, migrations, 
family compositions, conjugal relationships, pregnancies, parental status are collected on residents 
as well as non-residents who retain membership of households in the demographic surveillance 
area (DSA). This information is updated six monthly. The population is almost exclusively Zulu-
speaking and while predominantly rural, it contains an urban township and informal peri-urban 
settlements. Although predominantly a rural area, the main source of income for most households 
is waged employment and state pensions rather than agriculture. In 2006, approximately 77% of 
households in the surveillance area had access to piped water and toilet facilities. There is a high 
prevalence of HIV in the area (21.5% among people age 15-49, 51% among women aged 25-29, 
and 44% among men aged 30-34), and a large proportion of the deaths in the area currently could 
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be attributed to AIDS.(106) In 2003, population-based HIV testing (population based cohort) was 
started in ACDIS through annual surveys for all resident men age 15-54, all resident women age 
15-49, as well as 12.5% of non-residents of these ages.(12) This survey is the first of its kind in 
South Africa to investigate HIV/AIDS prevalence in a rural setting among residents and non-
residents and was complemented by an ART roll out program in 2004. The ART program is a 
partnership between the local department of health and the Africa Centre for Health and 
Population Studies of the University of KwaZulu- Natal, in Mtubatuba, and delivers care and 
treatment to HIV/AIDS patients through a decentralized network of primary health care clinics. By 
July 2008, over 5200 patients were being treated at clinics within the surveillance area.(106)  
Measurements of CD4 counts are done every 4 - 6 months for HIV patients receiving highly active 
antiretroviral treatment (HAART). The Africa Centre HIV surveillance provide test results through 
a Voluntary Counselling Test (VCT) paradigm, as it is done in government testing services.  
2.3 Study Design 
This study is a secondary data analysis of an analytic cross-sectional study nested in a prospective 
clinical cohort at Africa Centre (AC) in rural KwaZulu-Natal, South Africa.  
2.4 Study Population and Sample Size  
The study population included all adults (age ≥15) HIV positive patients attending KwaMsane 
clinic for ART from 7th November 2007 to 6th February 2008.  
The sample size comprised all 272 adult HIV positive patients on ART (age ≥15 years) who 
consented and were enrolled into the study from 7th November 2007 to 6th February 2008  
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2.4.1 Sampling  
 This original study adopted a convenience sampling technique of all adult HIV positive persons 
(age ≥15 years) who enrolled into the AC ART rollout program between 7th November 2007 and 
6th February 2008 and were accessing ART at KwaMsane clinic which is the biggest among the 
ART clinics. ART treatment counsellors based at the clinics introduced all patients coming for a 
routine ART visit to the study. The patients could then choose to see one of two research assistants 
who provided them with further information on the study and initiated informed consent process.  
A total of 272 persons who consented were interviewed and enrolled into the study after going 
through counselling. 
2.4.2 Inclusion criteria 
All adult (aged ≥15 years) patients who enrolled into AC ART programme between the periods 7th 
November 2007 to 6th February 2008 were eligible for the study. 
2.4.3 Exclusion criteria 
HIV positive patients who began ART treatment for less than 4 months and women who were 
pregnant at the time of this study were excluded.  
2.5   Data Sources 
Secondary data of all the 272 patients on ART who were interviewed was obtained from the AC 
ART Adherence Study for analysis. For data collected as part of the HIV survey, teams of two 
trained fieldworkers visited each eligible individual in his or her household on an annual basis. 
The information was stored in a single MS-SQL Server database, in a longitudinal way. The 12-
item General Health Questionnaire (GHQ12) which is used to measure both depression and 
anxiety in a population was used to assess the mental health status of HIV patients on the ART 
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program. The GHQ12 was administered together with the ART adherence questionnaire by the 
trained field workers in Zulu and the coded responses for each variable/participant were added up 
and stored in the MS-Excel database. For the purpose of this study data was extracted from these 
sources and exported to STATA 10 for analysis. 
General Health Questionnaire (GHQ) 
The GHQ was developed by Professor David P Goldberg and is a versatile screening questionnaire 
that is used in both general medical settings and populations to assess psychiatric disorders. It has 
been shown to be a valid instrument for measuring mental disorders such as depression and 
anxiety(52-55).  The GHQ was originally designed as a 60-item instrument but several shortened 
versions are now available, including the GHQ-30, GHQ-28, GHQ-20 and GHQ-12. The shortest 
version of the questionnaire (GHQ-12) has been extensively validated and used in a number of 
countries and in more than 30 different languages throughout the world.(23, 55-61)Error! Bookmark not 
defined.   For example, Gureje and Obikoya in a primary care setting study in Nigeria 
demonstrated in their findings the feasibility of using the GHQ12 in Yoruba.(55)  The GHQ12 
assigns scores to each respondent according to their answers to a number of questions ranging 
from “better than usual” to “much less than usual” for positive response category and “not at all” 
to “much more than usual” for negative category. The GHQ12 has six (6) positively worded 
questions (items) and six (6) negatively worded questions (items) with their respective scoring 
methods. The 4 categories of responses are coded 1, 2, 3 and 4   and scored 0 = 1, 0 = 2, 1 = 3 and 
1 = 4 (i.e. 0 0 1 1), and the scores for each participant are summed up and dichotomised into 
pathological (using a threshold) and non-pathological. Although a default threshold of 1 or 2 is set, 
the User’s Guide for the GHQ (Goldberg and Williams 1988)(53) recommend that the best 
threshold score is determined in each country or setting in which it is intended to be used. 
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However, it is recommended that higher threshold be use in the case of physically ill participants 
(See Appendix 4 for type of questions and scoring methods).  
2.6 Data Collection 
The data was collected from 7th November 2007 to 6th February 2008 in adult HIV/AIDS patients 
(age ≥15 years) by use of General Health Questionnaire 12 (GHQ12) to assess mental health status 
(depression). The GHQ12 in addition to the ART adherence questionnaire (used to collect data on 
other factors) was administered in Zulu by trained interviewers and HIV counsellors to 272 HIV 
patients who consented to be part of the study between the period 7th November 2007 and 6th 
February 2008. The anonymity and confidentiality of participants were protected. The Zulu 
version of GHQ12 was provided (and validated in a pilot study) by Professor Arvin Bhana of 
University of KwaZulu-Natal (UKZN).  
2.7 Description and Measurement of Study Variables  
2.7.1 Explanatory variables 
Figure 1 below is a presentation of an epidemiological overview of variables used in the current 
study. Exposure variables are factors that are suspected to be associated with the outcome of 
interest which could be harmful or a particular behaviour or personal characteristic, and in the 
present study it relates to depression. The outcome is the condition which occurs as a result of the 
exposure and/or confounder. The confounder is a variable that is associated with the exposure of 
interest and a risk factor for the outcome of interest. 
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Figure 1: An overview of variables used in the present study 
           Exposures                                                                                                     Outcome 
 
 
 
                                                            Potential Confounders      
 
 
Social Support was measured using two orthogonal pc scores, the first capturing largely questions 
related to ‘instrumental social support” (tangible services that patients receives from network 
members such as, get help when sick, get financial assistance, transportation, advice about 
problems) and the second capturing largely questions related to “emotional social support” (given 
assurance to patients such as get love and affection) 
Six Coping strategies with HIV/AIDS infection (Avoided being with people in general, Tried to 
keep it from bothering you, Kept yourself from thinking too much about AIDS, Asked other 
people for advice and information, Talked to someone about how you were feeling about having 
HIV, Involved yourself in volunteer work or an AIDS community organization e.g. helping others 
with HIV /AIDS) with responses ranging from “all of the time” to “none of the time” were 
included in the analysis. Each of the coping strategies were categorised into binary outcomes of 
“0” for patients who are not able to cope and “1” for patients who are able to cope.    
Social Support 
Coping Strategies 
SES 
CD4 Cell Count 
 
 
Depression 
Gender 
Age 
Marital Status 
Education 
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Socio-economic status (SES) was measured using a principal component analysis (PCA) score 
summarizing information on household ownership of assets including telephone, cell phone, 
watch, alarm clock, radio/stereo, primus cooker/sikeni, electric hot plate, electric stove plate, gas 
cooker, fridge/freezer, electric kettle, television, video cassette recorder, block maker, sewing 
machine, car/bakkie, motorcycle/scooter, bicycle, kombi/lorry/tractor, table/chair, sofa, kitchen 
sink, wheelbarrow, hoe/spade,  bed nets, cattle and other livestock. These assets were categorized 
into “0” (patients who do not have the asset) and “1’ (patients who have the asset.) The assets were 
combined into a wealth index using weights derived through principal component analysis (PCA) 
using Stata 10.  
The model was based on the presence or absence of each asset i.e. each asset was dummied with 
the response, 0 and 1. We ran the PCA command in Stata to generate indices for all listed assets.  
The asset approach was used as recommended by Filmer and Pritchett(62) who in a study in many 
states of India, found that the asset index produces comparable results with other measures. The 
author noted that the asset index significantly correlated with the state head count index as well as 
the domestic product per capita distributions. 
 
CD4 cell count for patients were collected at nine (9) different times during the ART adherence 
study. Using Stata 10, we generated an absolute value for each CD4 cell count per patient and then 
grouped all the different values to get an average minimum values for each patient using the 
egenerate command in Stata. The average minimum CD4 cell count was then categorised into “0” 
for patients whose CD4 cell count ≤200, “1” for CD4 cell count>200 and “2” for missing. These 
categories were used in the final analysis to check for association between CD4 cell count and 
depression.    
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2.7.2 Other explanatory variables 
Gender, age, marital status and education are the other explanatory variables found in the literature 
that was controlled for in this study. Gender was categorised “1” male and “2” females.  Whereas 
Marital status had 3 categories namely: “1” single, “2” married and “3” cohabiting, educational 
status was categorised as follows: “1” none, “2” primary, “3” secondary and “4” matric/higher.  
2.7.3 Outcome variable 
The outcome variable is mental health status (depression) of HIV/AIDS patients on ART. We 
assessed depression in patients by use of the General Health Questionnaire (GHQ12). It was 
quantified by assigning scores to participants’ based on their responses to the questions.  In order 
to arrive at the outcome variable, the scores for each patient were summed up and dichotomised 
into pathological (above a threshold of 4 for cases) and non-pathological for analysis. Although, a 
default threshold of 1 or 2 is used in general population, it’s recommended that a higher threshold 
be used when participants are physically sick.(53) Therefore, a threshold of 4 or more was used in 
this study to identify patients who had depressive disorder.  From the literature we found that there 
are three (3) main possible methods (GHQ, C-GHQ and Likert scoring methods) of scoring the 
questionnaire,(52, 53, 63) the GHQ scoring method was used in the present study.   
2.8 Data Management 
Data handling, cleaning and statistical analysis was carried out using STATA version 10. Data in 5 
tables (3 ART Adherence study datasets, 1 CD4 cell count dataset and 1 baseline dataset) were 
stored in Microsoft excel spreadsheet and imported into STATA 10 using the import function. 
After importing the 5 datasets into Stata, there were all merged into a single master table. Data 
cleaning was performed involving the checking of quality of the data in terms of missing values, 
  
0708083F     
18 
internal consistencies and validity of responses, recoding and generation of variable.  The 
variables used in this study were selected from the 5 tables. The mental health (depression), 
gender, age (from date of birth and date of interview) SES, social support and strategies to cope 
with HIV infection data was obtained from the ART adherence study table 1; educational status 
obtained from both ART adherence study table 2 and baseline table; marital status data obtained 
from the baseline table and CD4 cell count data from the CD4 cell count table.                                                                                                         
2.9 Data Analysis 
2.9.1 Descriptive analysis  
Frequencies and percentages for categorical variables and means and standard deviations for 
continuous variables were used to describe all variables included in this study at 95% confidence 
interval  
2.9.2 Multivariate analysis  
Univariate and multivariate logistic regression analysis were carried out to investigate the effects 
of the independent variables on the outcome variable (depression) controlling for potential 
confounders at the 95% confidence interval. Four (4) multivariate logistic nested models were 
finally built to explain the effect of social support, coping strategies, SES and CD4 count on 
depression holding other variables constant. 
Model Selection 
We used a combination of back- and forward selection to build four nested regression models in 
the final analysis of the present study. We included in the analysis independent variables in our 
regression equations based on our substantive understanding of factors affecting depression (which 
is based on past studies).Variables (e.g. gender, age )that we strongly believe to be confounders of 
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the relationship between other variables and our outcome (depression) therefore were allowed to 
stay in the final model to control for such confounding regardless of their significance status   
 
Although we are not oblivious of the few penalties of including variables on the right hand side of 
regression equations (loss of d.f., multicolinearity, which we ruled out), the potentially penalties 
of excluding them (omitted variable bias) is larger and could lead to a bias towards selecting false-
positive results. 
In addition, it is also viewed that, the finding that some variables do not significantly affects 
depression (ceteris paribus) is an important one and worth sharing with our readers. 
 
2.10 Ethical Considerations 
Ethical approval for this study was obtained from the Human Research Ethics Committee of the 
University of Witwatersrand - Protocol number M080983 (Appendix 7) for the secondary data 
analysis. Ethical approval for the primary data collection was obtained by the ACDIS from the 
University of KwaZulu-Natal and the Harvard School of Public Health Ethics Committees 
(Appendix 3).  Informed consent was obtained from all participants before interview were 
conducted during the primary data collection. 
2.11 Dissemination of Results 
A presentation of the results of the study shall be made to staff of ACDIS, School of Public Health 
(SPH) of the University of the Witwatersrand and the Navrongo Health Research Centre (NHRC). 
The results will also be disseminated at scientific conferences and published in peer-reviewed 
journals. 
  
0708083F     
20 
CHAPTER THREE 
 3.0 RESULTS 
 
3.1 Introduction 
This chapter presents the results of the analysis for this study in five (5) parts involving all 272 
participants on ART who were included in the analysis of this study.  The first part deals with the 
main characteristics of participants and describes the prevalence of depression among patients.  
In the second part, the result of a regression model where we examined the effect of social support 
(instrumental social support and emotional social support) on depression outcome while holding 
the other variables (gender, age, marital status, education and SES) constant are presented. The 
third part deals with a model in which we added six (6) strategies to cope with HIV/AIDS 
infection (Avoided being with people in general, Tried to keep it from bothering you, Kept 
yourself from thinking too much about AIDS, Asked other people for advice and information, 
Talked to someone about how you were feeling about having HIV, Involved yourself in volunteer 
work or an AIDS community organization e.g. helping others with HIV /AIDS) to examine their 
effect on the outcome of depression while holding the socio-demographic variables as well as 
instrumental and emotional social support constant. In the fourth part, we investigated the effect of 
two other factors namely SES and CD4 cell count on depression in patients. We constructed a 
wealth component score that summarizes information on 27 household assets for the year 2008 
using PCA to estimate socio-economic status. Further, we added a clinical factor (CD4 cell count) 
to the final model and investigated whether this factor affects depression in patients on ART.  
Finally, we looked at the effect of the socio-demographic factors on depression as we adjusted for 
them in all the four models we built. 
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3.2 Patients Characteristics   
A summary of selected patients characteristics are presented in table 1 for all 272 patients on ART 
who were enrolled into the current study. The mean age of patients was 38 years with a range 
between 20 and 67 years (SD=8.7). There was a high proportion of females 214 (78.68%) 
compared to males 58 (21.32%) during the period under study.  Analysis of marital status revealed 
that majority of patients were single (73.42%), with 21.17% who were married and a further 
5.42% cohabiting. The educational status profile showed that majority of patients (40.9%) had 
secondary education; over nineteen percent (19.3%) had matric or higher education. Whereas 
29.7% had primary education, 10% of patients did not have any education.   Analysis of patients 
CD4 cell count showed that more than half of the patients (57.4%) had CD4 cell count >200, and a 
further 30.9% had CD4 cell count ≤ 200. The median CD4 cell count for patients was 276 (SD = 
205.6) and range between 15 and 1169. 
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Table 1: Descriptive summary statistics of selected variables for HIV/AIDS patients on ART 
by Depression status 
        
Variable 
Depressed 
n=90 
Not Depressed 
n=182 
         Total n(%) 
          N=272 
 
Gender  n(%) 
               Male 
               Female 
 
 
 
  15 
  139 
 
 
    43 
    75 
 
 
            58  (21.32) 
          214  (78.68) 
Age Group 
             20-29 
             30-39 
             40-49 
             50-59 
             60-69 
 
 
  14 
  34 
  30 
  10 
  2 
 
 
    32 
    80 
    56 
    11 
    3 
 
           46 (16.91) 
         114 (41.91) 
           86 (31.62) 
           21 (7.72) 
             5 (1.84) 
 
 
Marital status n(%) 
                Single  
                Married 
                Cohabiting 
                 
 
 
  50 
  19 
  6 
 
 
 
    113 
    28 
    6 
 
 
           163  (73.42) 
             47  (21.17) 
             12   (5.41) 
 
Education n(%) 
                None  
                Primary  
                Secondary  
                Matric/higher 
 
  9 
  33 
  37 
  9 
 
    17 
    45 
    72 
    42 
 
             26  (10.04) 
             77  (29.73) 
           106  ( 40.93) 
             50  (19.31) 
 
CD4 cell count n(%) 
               ≤200 
               >200 
               Missing 
 
  36 
  39 
  15 
 
    48 
    117 
    17 
 
             84  (30.88) 
           156  (57.35) 
             32  (11.76) 
 
 
 
3.3 Prevalence of depression in HIV patients on ART 
Figure 2 showed an overall depression prevalence of 33% among patients on the GHQ scoring 
method which has been used in this study.  Females who constitute about 79% of the study sample 
had a higher depression prevalence of 35% compared to 26% male prevalence. However, the 
 gender difference in depression prevalence was not statistically significant as indicated by the 
overlapping confidence bands in figure 2 below. We found similar results when we further 
conducted a two-way sample proportion test to check whether there is significant d
gender (P= 0.196).  
Figure 2: Gender and overall prevalence of depression in patients on ART  
 
The results also demonstrate that there is an association between the prevalence of depression and 
patients CD4 cell count group. Lower CD4 cell count (
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depression prevalence of 42.9% compared to 21.3% for patients with CD4 cell counts above 200. 
The differences in the depressed and not depressed group for patients with CD4 cell count >200 
was significant as indicated by the un-overlapping confidence bands but not significant for patients 
with CD4 cell count ≤200 as is demonstrated in Figure 3.  
 
Figure 3: Prevalence of depression in HIV-patients on ART by CD4 cell count groups  
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3.4 Social Support 
The results of this study indicate that instrumental social support and not emotional social support 
significantly affect depression in patients on public-sector ART.  In univariate analysis (SeeTable 
2), the odds of patients to be depressed who had good instrumental social support was 40% less 
compared to patients who did not have good instrumental social support (OR = 0.6 P<0.001, 95% 
CI 0.52 - 0.74). In multivariate analysis in table 3 (Model II) where we adjusted for other factors 
(sex, age, education, marital status and SES) instrumental social support still remained a 
significant predictor of depression among patients throughout the three nested models. The 
adjusted odds of depression was 30% less for patients who had good instrumental social support 
(OR= 0.7 P<0.00, 95% CI 0.52 - 0.81) compared to patients who had poor instrumental social 
support. The effect of instrumental social support remained a highly significant predictor of 
depression (Table 3) when we added six (6) coping strategies with HIV/AIDS to the variables in 
Model III (OR = 0.7 P<0.001, 95% CI 0.51 - 0.83) and in the final model IV (OR = 0.7 P<0.001, 
95% CI 0.52 - 0.85) where we added CD4 cell count to the variables holding other factors 
constant. 
3.5 Coping Strategies with HIV/AIDS Infection 
Both univariate and multivariate analysis  showed that “avoidance of people” and “try to keep it 
(HIV/AIDS) from bothering you”  are the two strategies in this study that  are significantly 
associated with depression in patients among the six(6) strategies to cope with HIV/AIDS (see 
Tables 2 and 3). Univariate analysis results depicted in Table 2 showed that, “avoidance of 
people” as a strategy to cope with HIV/AIDS increase the odds of depression threefold (OR = 3.1 
P<0.001, 95% CI 1.76 - 5.3) and remains significant also in multivariate analysis (See Table 3) 
where we held other variables constant (OR = 2.8 P=0.006, 95% CI 1.34 - 5.82). The odds of 
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being depressed is reduced by 40% for patients who try to keep it (HIV/AIDS) from bothering 
them (OR = 0.6 P=0.07, 95% CI 0.32 - 1.06) in the univariate analysis, and reduced by half (50%) 
in   multivariate analysis (OR = 0.5 P=0.07, 95% CI 0.20 - 1.06). Although the odds of patients 
who do not involve themselves in volunteer work or an AIDS community organization (e.g. 
helping others with HIV/AIDS) is increased almost twofold in the univariate analysis ( OR=1.8 P= 
0.29 95% CI 0.62 – 4.91) and threefold in the multivariate analysis(OR=2.7 P=151,  95%CI 1.69 - 
10.73), it was not statistically significant  
 
3.6 Socio-Economic Status (SES) 
The analysis of SES in both univariate and multivariate models revealed an association between 
SES and depression among HIV patients on ART. The unvariate analysis in table 2 indicates that 
higher SES was significantly associated with decreased depression among patients on ART. The 
odds of being depressed was decreased by 20% for patients who had a higher SES score (OR=0.8 
P=0.001, 95% CI 0.71 – 0.92). A similar association was demonstrated in the multivariate analysis 
in table 3 (Model I) where SES still remained a significant predictor of depression (OR=0.8 
P=0.016, 95% CI 0.70 – 0.97) among patients on ART holding other variables (sex, age, marital 
status and education) constant.  However, it is important to add that the effect of SES was 
diminished (no longer significant) when we further adjusted for social support in model II and the 
six (6) coping strategies in Model III and CD4 cell count in Model IV. 
3.7 CD4 cell count 
The results of both univariate and multivariate analysis demonstrate that CD4 cell count was 
significantly associated with depressive outcome among patients on ART. There was an inverse 
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functional relationship between CD4 count and depression; higher CD4 count predicted lower 
depression and lower CD4 count predicted higher depression among patients. Univariate model in 
Table 2 demonstrated that the odds of being depressed among patients whose CD4 cell count >200 
was reduced by 60% comparing patients with CD4 cell count ≤200 holding other variables (sex, 
age, education, marital status, SES, social support and copping strategies) constant (OR=0.4 
P=0.005, 95%CI 0.25 – 0.78).  The multivariate model shows an adjusted odds ratio of 0.5 for 
patients with CD4 cell count ≤200 in the final model constant in table 3 (P=0.038, 95%CI 0.21 - 
0.96). 
3.8 Socio-demographic factors 
In both univariate and multivariate models, the four (4) socio-demographic variables (gender, age, 
marital status and education) were included in the analysis of this study and none assumed 
statistical significance (See Tables 2 and 3). Although in the univariate analysis females had a 
higher odds of being depressed compared to males, it did not assume statistical significant 
(OR=1.6 P=0.189, 95% CI 0.81 - 2.97). In multivariate analysis, the odds of being depressed for 
males was equal to the odds of being depressed for females as shown in table 3. The analysis of 
educational status revealed an observed trend in which higher education is associated with 
decreasing depression in patients on ART in both the univariate and multivariate models. The odds 
of being depressed for patients who attained matric/higher education is reduced by about sixty 
percent (60%) in the univariate analysis shown in table 2 (OR=0.41 P=0.101, 95%CI 0.14 - 1.20) 
and fifty percent (50%) in the multivariate analysis in shown in table 5 (OR=0.5 P=0.101, 95%CI 
0.11-1.85) compared to patients who have no education. This observed trend however did not 
assume statistical significance as all the P-values were >0.05 and the confidence intervals included 
“1”  
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Table 2: Univariate logistic regression analysis of factors associated with depression in HIV-
positive patients on ART  
Variable    OR               95%CI          P-value 
Gender 
        Male 
        Female 
 
Age (years) 
 Marital Status 
        Single 
        Married 
        Cohabiting 
Highest Education 
        None 
        Primary 
        Secondary 
        Matric/higher 
SES 
       Low 
       High 
Social Support (instrumental)      
      Low 
      High         
Social Support (emotional) 
     Low 
     High 
Coping Strategies with HIV/AIDS Infection 
Avoided being with people in general 
                   No 
                  Yes 
Tried to keep it from bothering you 
                  No 
                 Yes 
Kept yourself from thinking too much about AIDS 
                 No 
                 Yes 
Asked other people for advice and information 
                 No 
                 Yes 
Talked to someone about how you were feeling about having HIV 
                 No 
                 Yes 
Involved yourself in volunteer work or an AIDS community 
organization (e.g. helping others with HIV /AIDS) 
                 Yes 
                  No 
CD4 cell count 
         ≤200 
         >200 
  
    1 
    1.55           0.81 – 2.97         0.189 
 
    1.02           0.99 – 1.05         0.238  
 
    1 
    1.53           0.78 – 2.99         0.212   
    2.26           0.70 – 7.35         0.175   
  
    1 
    1.39           0.55 – 3.49         0.490  
    0.97           0.40 – 2.39         0.948   
    0.41           0.14 – 1.20         0.101   
    
    1 
    0.81           0.71 – 0.92         0.001   
   
    1 
    0.62           0.52 – 0.74         0.001 
       
    1 
    1.08           0.88 – 1.34         0.461    
 
    
    1 
    3.07           1.76 – 5.36         0.001   
     
    1 
    0.59           0.32 – 1.06         0.079    
    
    1 
    0.90           0.53 – 1.53         0.698      
    
    1 
    1.75           0.80 – 3.82         0.159     
    
    1 
    1.24           0.73 – 2.12         0.428      
   
    
    1 
    1.75           0.62 – 4.91         0.287      
     
    1 
    0.44           0.25 – 0.78         0.005     
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Table 3: Multivariate regression analysis showing  effect of social support, coping strategies, SES and CD4 count on 
depression holding other variables constant in patients on ART   
 
            
 
   Variable 
                                                         
                                       Odds Ratio   (95% Confidence Interval)*  
 
       Model  I                  Model  II                    Model  III                    Model  IV 
          
Gender 
        Male 
        Female 
 
Age (years)                                                                                                                                           
Marital Status 
        Single 
        Married 
        Cohabiting 
Highest Education 
        None 
        Primary 
        Secondary 
        Matric/higher 
SES       
       Low 
       High                                                                
Social Support (instrumental)     
       Low 
       High             
Social Support (emotional) 
       Low 
       High 
Coping Strategies with HIV/AIDS                                                                    
Avoided being with people in general.      No    
                                                                   Yes 
Tried to keep it from bothering you.          No 
                                                                   Yes           
Kept yourself from thinking too much about 
AIDS.                                                        No                                     
                                                                  Yes 
Asked other people for advice and information 
                                                                   Yes 
                                                                   No 
Talked to someone about how you were feeling 
about having HIV                                      Yes 
                                                                    No 
Involved yourself in volunteer work or an AIDS 
community organization (e.g. helping others with 
HIV /AIDS)                                                 Yes 
                                                                     No 
CD4 cell count 
         ≤200 
         >200 
 
         
             1                               1                                   1                                   1 
  1.00(0.44-2.29)           0.88(0.37-2.08)           0.97(0.38-2.43)             1.04(0.40-2.68) 
    
0.99(0.95-1.04) 1.00(0.96-1.05)  1.01(0.97-1.07)             1.01(0.96-1.06)   
      
             1                                 1                                   1                                  1 
  1.69(0.75-3.81)           1.49(0.64-3.49)            1.29(0.52-3.19)            1.42(0.56-3.58)    
  3.05(0.75-12.33)         1.63(0.39-6.90)            1.74(0.38-7.86)            1.65(0.36-7.63)  
                    
             1                                1                                     1                                  1 
  1.17(0.41-3.41)           1.14(0.39-3.36)           1.44(0.45-4.58)             1.71(0.51-5.74)      
  0.95(0.32-2.81)           0.87(0.28-2.66)           1.13(0.35-3.69)             1.13(0.33-3.87) 
  0.45(0.11-1.85)           0.56(0.13-2.42)           0.84(0.18-3.95)             0.91(0.19-4.38) 
  
             1 
  0.82(0.70-0.97)*         0.90(0.76-1.07)           0.86(0.73-1.04)             0.87(0.72-1.04) 
                                      
                                                1 
                                0.65(0.52-0.81)***     0.65(0.51-0.83)***       0.65(0.52-0.85)***     
                                      
                                                1 
                                     1.00(0.78-1.30)           0.99(0.75-1.31)             1.01 (0.76-1.34) 
 
                                                                                   1                                  1 
                                                                      2.79(1.34-5.82)**         2.86(1.36-6.04)**   
                                                                                   1                                   1 
                                                                        0.45(0.20-1.06)*           0.45(0.20-1.07)*  
 
                                                                                   1                                    1                                          
                                                                         0.68(0.33-1.41)             0.70(0.33-1.45) 
 
                                                                                   1                                   1                                                      
                                                                         1.46(0.51-4.23)             1.35(0.46-4.00) 
 
                                                                                     1                                  1 
                                                                         1.33(0.64-2.79)             1.26(0.59-2.70)   
   
                                                       
                                                                                      1                                 1 
                                                                         2.73(1.69-10.73)           2.11(0.54-8.36) 
                                                                                  
                                                                                                                        1 
                                                                                                             0.45(0.21-0.96)*                                     
Note:   *P< 0.05        **P< 0.01        ***P< 0.001 
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CHAPTER FOUR 
4.0 DISCUSSION AND CONCLUSION 
 
4.1 Discussion 
To our knowledge this is the first study that examined the effect of social support on depression 
outcome in HIV/AIDS patients on a public sector ART programme in rural South Africa. The 
identification of the factors that affect depression in HIV/AIDS patients on ART is useful because 
they provide clues to the aetiology of depression and its pathogenesis(64). Clinically, they also 
enable physicians to formulate a more accurate prognosis since predictors of response to specific 
medications are very important in selecting treatments. In this study, we investigated whether 
social support (instrumental and emotional) affects the outcome of depression in HIV/AIDS 
patients on antiretroviral treatment program. Participants in this study were patients assessing ART 
in one of the major treatment centers (KwaMsane clinic) for HIV/AIDS in the biggest cohort ART 
rollout program in South Africa.  
Considering the fact that South Africa is one of the hardest hit by HIV/AIDS pandemic (UNAIDS 
2007) and that psychiatric disorders contribute substantially to the burden of disease(65), the 
understanding of the relationship between the four variable (social support, coping strategies, SES 
and CD4 count) under discussion and mental disorders such as depression could be crucial to the 
mental and physical health among HIV/AIDS patients seeking treatment.  
 
As mentioned earlier, we included the independent variables in our regression equations based on 
our substantive understanding of factors affecting depression based on past studies. We also 
checked whether duration on ART affected depression outcome and whether it was associated 
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with any of the explanatory variables but there was no effect or association. Variables which we 
strongly believe to be confounders of the relationship between other variables and our outcome 
(depression) therefore were allowed to stay in the final model to control for such confounding 
regardless of their significance status   
 
The present study’s 33% overall depression prevalence rate  among HIV/AIDS patients on ART 
using  the GHQ scoring method is similar to findings from other studies (using GHQ scoring 
method) done in a similar context (51, 66-70) and other places.(7) However, some researchers have 
found either higher (43%)(71) or slightly lower depression prevalence rates.(49, 72, 73)   
In order to have a robust scoring method in measuring the outcome of depression, we assessed 
whether the three (3) main GHQ scoring methods (GHQ, C-GHQ and Likert) gave consistent 
results in this population.  The results (data not shown) indicate that there are no significant 
differences in prevalence of depression with respect to scoring methods. We further conducted a 
test of two-way sample proportion and chi-square test and all the P-values were >0.05, with the 
corresponding confidence intervals overlapped confirming no significant difference (see Appendix 
1). Therefore, in the present study we used the GHQ scoring method which has not only been 
recommended by David Goldberg who developed the questionnaire, but also used by other 
researchers in similar context.(50, 55)  Although the three (3) methods score differently, the scores 
are summed into pathological (depressed) or non-pathological (not depressed) using thresholds 
and this may explain the consistency in results. 
Females (who constitute 79% of the study sample with a high HIV infection in the study area) had 
a higher depression prevalence of 35% compared to 26% male prevalence. Similar to most studies, 
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the gender difference in depression prevalence among HIV patients was not statistically 
significant(figure 2) in our study.(66, 74) We found similar results when we further conducted a two-
way sample proportion test (not shown) to check whether there is a significant difference by 
gender (P= 0.196). It is of interest to note that Olley and colleagues who examined predictors of 
depression in recently diagnosed patients with HIV/AIDS in South Africa found no significant 
difference in depression prevalence by gender.(47)  However, Margaret and her colleagues in a 
study of the prevalence of psychiatric disorder in a South African general hospital and Freeman 
and Colleagues  who investigated the prevalence of mental disorder in PLWHA in South Africa 
both found significant difference in gender.(49, 50, 66)  Steffens and colleagues found similar results 
in a study of depression prevalence among the elderly in America.(75)  
The results of this study support the hypothesis that social support and coping strategies affect the 
outcome of depression in HIV/AIDS patients on ART in rural South Africa.  The finding 
demonstrates strongly that instrumental rather than emotional social support is an important factor 
that affect depressive outcome in patients on ART as the odds of depression among patients who 
had adequate/good instrumental social support is 35% less compared to patients who did not have 
adequate/good instrumental social support (P<0.001, 95%CI 0.52 – 0.85). The other three (3) 
explanatory variables (SES, copping strategies and CD4 cell count) included in the analysis of this 
study were also found to be significant associated with depression, we discuss the details later in 
this section of the report. 
The results of this study could have been expected because evidence from previous studies 
suggests an association between social support, SES and CD4 cell count and the outcome of 
depression.(76, 77)  Our findings therefore provide further evidence to the important role of social 
support in particular and SES, coping strategies and CD4 cell count in general to the outcome of 
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depression in HIV/AIDS patients in a public sector ART program.  The results particularly reveal 
that instrumental rather than emotional social support affect depression in patients on ART. 
4.1.1 Social Support and outcome of depression 
Social support, defined as emotional, informational, or instrumental assistance from others(78), has 
been associated with better health, faster recovery from illness, and lower risk for mortality(79, 80)  
We measured social support using two orthogonal pc scores, the first capturing largely questions 
related to ‘instrumental social support” (tangible services that patients receives from network 
members such as, get help when sick, get financial assistance, transportation, advice about 
problems) and the second capturing largely questions related to “emotional social support” (given 
goodwill and assurance to patients such as get love and affection). We analysed social support 
using two scores in order to allow us identify which particular aspect of social support 
significantly affects depression in HIV/AIDS patients on ART. This categorisation is consistent 
with previous studies done elsewhere which have used similar categories to examine the effect of 
social support on depression in patients on ART.(69, 81)  
Evidence from studies of people with HIV infection suggest that social support is critical for 
emotional well-being and during periods of crisis, family support may become an especially 
important determinant of emotional well-being.(82, 83) In direct relevance to the present study, 
Gurung and colleagues found that higher levels of social support from friends and from family 
made independent contributions to lower depression in persons infected with HIV/AIDS.(84) (79, 85)   
The results strongly suggest that instrumental social support rather than emotional social support is 
significantly associated with depression among HIV/AIDS patients on ART in a public-sector 
ART roll out program. Although the design of our study is cross sectional and unable to establish 
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causality, the findings suggest that poor social support (instrumental) may precede the onset of 
depressive symptoms and could be a characteristic of the social lives of patients prone to 
depressive symptoms.  Also, showing of goodwill and giving assurance to patients may not be a 
sufficient antidote to prevent the onset or treatment of depression, but rather the quality of 
instrumental social support received by HIV patients  positively impacts on the level of depression 
they experience.  Even when non-significant variables were eliminated from the final model IV in 
the regression analyses; there were only minor changes in the adjusted R2 value and the odds ratio 
(See Appendix 2) for instrumental support remained the same. 
Social support has several domains and some studies suggest that it operates best when matched to 
a particular context and situation.(108 109 110) Sometimes, people simply want companionship; they 
want others to participate, or join them in their excitement. But in some situations, they want 
others to be there to provide them with support, encouragement, or displays of love. It may be the 
case that instrumental social support operates best in this context. Therefore, the categorisation of 
social support as instrumental and emotional in this study does not necessarily means emotional 
social support is not an important.   
 
 The presence of quality instrumental social support protects HIV/AIDS patients against the onset 
of depression; thus, the probability that a patient will suffer from a depressive episode appears to 
be influenced by social support. The present study’s finding is consistent with existing literature(69, 
76, 77, 86-89)
.  For example, Robbins and his colleagues in a study of the protective role of family and 
social support network among HIV positive women found that social support is an important 
moderator of the relationship between changes in CD4 cell count and psychological distress 
(anxiety and depression).(85) Similarly, Gazmararian and colleagues in a study of multivariate 
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analysis of factors  associated with depression in the USA demonstrated that available social 
support  was a strong predictor of depression, and that individuals who were currently married or 
had better social support had lower depression.(77)   Hirschfeld in a systematic review of literature 
on psychosocial predictors of outcome of depression found that social support offers protection 
against the development of depression in persons in stressful situations.(64) His findings provide 
evidence that individuals with low social support are at greater risk of developing depressive 
symptoms. Similarly Flaherty and colleagues found that patients with high social support had 
significantly better depressive rating scores than patients with low social support. It is important to 
state that instrumental rather than emotional social support is the strong predictor of depression 
found in this study. This means that patients are more affected by availability of tangible social 
support services that patients receive from network members such as getting help when sick and 
get financial assistance, to them when in need than emotional social support. This finding is 
consistent with other research that shows subjective social support as the most important 
dimension of support relating to depression.(69, 76)Error! Bookmark not defined. For example, 
Spoozak and colleagues in a study evaluating a social support measure that may indicate 
depression during pregnancy demonstrated that frequency of contact from mother or father was 
important to over all social support. Similar our categorisation of social support, Vyavaharkar and 
colleagues have reported that there is an association between social support and adherence in a 
study which examined social support, coping, and medication adherence among HIV-positive 
women with depression living in rural areas of the Southeastern United State.(81)  
Further analysis showed some correlation between social support and SES (Pearson correlate = 
0.36). The two factors were significantly was moderately correlated (P <0.05). It may be the case 
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that the effect of social support is mediated through SES, but that is not clearly supported by the 
result of the present study. 
In conclusion, the findings of the present study strongly demonstrate that instrumental social 
support is significantly associated with depression outcome in HIV-positive patients on ART, even 
when we adjusted for all other factors in the final model. The quality of social support received by 
patients on ART affects the likelihood of developing depression; the better the quality of 
instrumental social support available to a patient on ART the lesser the likelihood of being 
depressed, and the poorer the availability of instrumental social support the greater the likelihood 
of being depressed. 
4.1.2 Coping strategies with HIV/AIDS infection and the outcome of depression 
Coping strategies refer to the specific behavioural and psychological efforts that people employ to 
master, tolerate, reduce, or minimize stressful events.(90)  Researchers have especially 
distinguished between approach and avoidance coping strategies: An individual can approach a 
stressor and make active efforts to resolve it or try to avoid the problem.(91)  Generally, people who 
rely more on the approach strategy adapt better to life stressors and experience less negative effect 
than those who make use of avoidance strategy. Therefore, active coping strategies may represent 
a resource that can reduce the likelihood of depression in the context of HIV infection. 
In the present study  “avoid being with people in general” and “try to keep it (HIV/AIDS) from 
bothering you” were the two (2) important factors among the six (6) strategies to cope with 
HIV/AIDS infection that were found to be significantly, associated with the outcome of depression 
in patients on ART. Whereas “avoid being with people in general” as a coping strategy was found 
to negatively associated with depression, “try to keep it (HIV/AIDS) from bothering you” was 
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found to be positively associated with depression. Even when we further eliminated the four non-
significant coping strategies from the model (data not shown) the effect of the two significant 
coping strategies did not change as the adjusted R2 only changed slightly and the odds ratios 
remained the same.   
Similar to the variables used to measure coping strategies in our analysis, Vyavaharkar and 
colleagues who examined social support, coping, and medication adherence among HIV-positive 
women with depression living in rural areas of the southeastern United States measured coping 
responses using eight (8) variables.(87)  They found, coping by denial/avoidance, were positively 
correlated with reasons for missed medications.  
We further investigated whether there is any correlation between coping strategies and social 
support. The results largely showed no correlation except “tried to stop bothering” (P = 0.177) and 
“kept yourself from thinking too much about AIDS” (0.691) which showed little correlation. This 
suggests that patients who have good social support are able to cope better with HIV infection 
compared to those who do not have good social support. 
Although, “involved yourself in volunteer work or an AIDS community organization (e.g. helping 
others with HIV /AIDS)” had a an OR = 2.1 indicating that patients who did not involve 
themselves in volunteer work or AIDS community organisations were two times more likely to 
experience depression compared to those who involved themselves, it did not reach significant 
level. This may be explained by the fact that in the study area, volunteer work and AIDS 
community organisations are not common.  
The findings of this study suggests that avoiding being with people as a strategy to cope with 
HIV/AIDS infection is inversely related to depression among patients on ART, and trying to keep 
HIV/AIDS from bothering you was found to be positively associated with lower depression. We 
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found no association between the other four (4) coping strategies and depression outcome in 
patients on ART.  
4.1.3 Socio-economic status (SES) and depressive outcome 
Depression is slightly more prevalent in people of lower SES than people of higher SES. Previous 
studies have shown that poverty and HIV prevalence are related in South Africa and poverty and 
mental health are also related.(70, 92-94) It may be the case that poverty and HIV/AIDS exacerbate 
each other and in combination impact on mental health leading to higher prevalence of mental 
illness than are expected for other very poor people or those who have HIV but are not poor. The 
vicious circle may be further exacerbated by the possibility that poor mental health can be a risk 
factor for both poverty and HIV/AIDS as well as a consequence of both of them   The findings of 
this study demonstrate that HIV patients of lower SES were more likely to be depressed than 
patients of higher SES (See Table 3, Model I), and these findings are similar to other findings from 
other studies that have suggested an association of low SES and depression.(84)  
Although SES was a significant predictor of depression in patients on ART in multivariate 
analysis (Model I) where we adjusted for gender, age, marital status and education, the association 
was no longer significant when we additionally adjusted for social support in Model II. The 
reasons for such a development are not known in this study as further analysis showed there was a 
moderate correlation between  SES and social support (Correlation = 0.36). It may be the case that 
patients who belong to higher SES have better social support. Although our findings suggest SES 
to be a predictor of depression among patients, the causal pathway of this association is likely 
through social support.  
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4.1.4 CD4 cell count and the outcome of depression 
In the present study, higher CD4 cell count (>200) was found to be associated with lower 
depressive outcome compared to patients who had lower CD4 cell count (≤200). After we further 
controlled for socio-demographic factors (sex, age, marital status, and education), SES, social 
support and coping strategies, higher CD4 count (>200) was still found to be significantly 
associated with lower depression outcome in patients (P<0.05). There is conflicting evidence 
internationally about the association between CD4 cell count and depressive outcome in 
HIV/AIDS patients. The finding of the present study is supported by Ickovics and colleagues   
who demonstrated that depressive symptoms are associated with lower CD4 cell count and disease 
progression.(26, 77, 95)  Furthermore, Robbins and colleagues who examined the protective role of 
family and social support in African American HIV-positive women demonstrated that changes in 
CD4 count were inversely associated with psychological distress (women with lower CD4 count 
showed greater psychological distress).(76)      In contrast, other studies carried out in South 
Africa(66, 68, 94, 96) did not find any significant association between CD4 count and depression. For 
instance, Moosa and colleagues(96) in a study in Gauteng province in South Africa concluded that 
there is no significant difference in the CD4 cell counts between depressed and non-depressed 
groups of HIV infected people Similarly, Melvyn Freeman in a study of mental disorder in people 
living with HIV/AIDS in South Africa found no significant association between CD4 cell count 
and presence of mental disorder.  It should be noted that although we found an association 
between CD4 count and depression, we are unable to make definitive statements/conclusions since 
the present study is cross sectional. For instance, since all patients are on ART it is not clear 
whether knowledge of improved changes in CD4 counts may have influenced the reporting of 
lower depression for patients with higher CD4 counts. Again, it’s possible that the higher CD4 
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count may have influenced other biological or physiological factor not accounted for in the present 
study which in turn influences depression. Further longitudinal study is recommended to establish 
this relationship.  
 
4.2 Implications and Recommendations 
The results of this study indicate high depression prevalence in people on ART in rural South 
Africa and needs to be addressed in ART programmes. Our analysis suggests specific possible 
ways to address depression in patients on ART 
Our findings demonstrate that instrumental social support influence depression in patients on 
ART, and these findings have practical public health implications for the development of 
interventions/measures to prevent the onset of depression and treatment. First, because depression 
is a burden adding to the already existing problems of HIV/AIDS, efforts at reducing the level of 
depression or treatment will help a lot in minimizing the painful experiences of patience of PLWA. 
Although ART has been rolled out across South Africa and other African countries, there has not 
been any program aimed at preventing or treating depression among patients receiving treatment.  
The results of the present study therefore highlight the need for programs aimed at addressing this 
major health concern. The absence of clinically significant symptoms of depression is often 
characterized by the ability to achieve and maintain positive psychological states of mind(97).Since 
studies have demonstrated that depressive symptoms and depressed mood predict decrements in 
CD4 cell counts and increases in HIV viral load among HIV-positive individuals on ART , thus 
reduce/impair adherence public health efforts to prevent or treat depression would be particularly 
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beneficial in terms of adherence and improved physical health of patience. (8, 22, 23, 98-101) This could 
be done through: 
First, group-based Interpersonal Psychotherapy (IPT) for patients on ART could be effective as 
evidence from studies have shown that that IPT is effective in the treatment of depression.(67, 102-104) 
Of particular interest to the current study is a randomized control trial done by Bolton and other 
researchers in rural Uganda which is similar to our setting and found IPT to be highly efficacious 
in depression reduction among patients.(102)  
Secondly, HIV counseling may also be refocused to help patience cope with the disease while on 
ART because patients who had better coping strategies were found to have lower depression. The 
education of health professional working with patients to identify early warning symptoms of 
depression and integration of mental health screening and referrals into routine as being protection 
against depressive symptoms suggests clinicians should routinely assess patients’ support 
networks and encourages their utilization and development. 
The psychosocial role of the consultation itself, both as listening support and as potential fresh-
start, should not be underestimated: if during consultation, attention is paid to the social context of 
a depressive episode, and adherence may thus be increased. 
Mental health affects progress towards the achievement of many Millennium Development Goals 
(MDGs) such as reversal of the spread of HIV/AIDS, improvement of maternal health, reduction 
of child mortality and promotion of gender equality and empowerment of women, therefore 
measures to reduce/treat depression in HIV patients will help achieve the MDGs particularly 
reversing the spread of HIV/AIDS. 
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4.3 Methodological Considerations 
4.3.1 Limitations of study 
A number of limitations of this study need to be mentioned. First, because this is a cross-sectional 
study design and cannot address questions of causality we cannot claim that low social support 
precedes depression. In order to determine if high social support protects a subject from depression 
onset, the study must be longitudinal and beginning with a group of subjects who have no current 
symptoms of depression. Also, there was no direct control group for comparison. 
Furthermore, in our model we did not control for prior history of depression. It would be important 
to see how a prior history of depression would influence the relationship between depression and 
social support, especially in a longitudinal analysis.  The results may not be generalised to urban 
populations since our study was done in predominantly rural area. 
4.3.2 Strengths of the study 
 Despite the above limitations, there were several notable strengths of the present study. This study 
was imbedded in a large ongoing prospective clinical cohort study on the biggest antiretroviral 
treatment roll out program in South Africa. Thus, it is a direct representation of HIV-positive 
patients on ART and we may be able to make generalizations in that regard.    
Secondly, the GHQ12 used to measure the outcome of depression was validated and scoring 
method robust. We did a method comparative study of the three (3) major methods used widely in 
various studies demonstrating that the GHQ scoring method used in the present study is robust.(52, 
53, 63)
 
The traditional GHQ scoring method was used to generate the outcome variable (depression). We 
first scored the data using the above three methods separately to get the overall and gender 
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prevalence of depression among patients by the various methods. We also performed one-sample 
test of proportion (prtesti) for overall prevalence and a two-way sample test of proportion (prtesti) 
for prevalence by gender to see if there are significant differences in the scoring methods. The 
tests showed that there are no significant differences between the various scoring methods, thus, 
whichever method is used will produce nearly the same prevalence (this is discussed further in the 
results section of this report). We chose to use the traditional GHQ scoring method recommended 
by Goldberg and used widely in both developed and developing countries.   
 Another notable strength of this study is that, unlike previous studies which examined social 
support generally, we differentiated between instrumental social support and emotional social 
support. This allowed us to investigate which particular aspect of social support affect depression 
in patients on ART so as to inform effective policy direction and intervention. The study clearly 
demonstrates that goodwill from social network of people for patients on ART is not enough to 
influence lower depression 
Finally, the inclusion of a biological factor (CD4 cell count) in the analysis strengthens the present 
study because it enabled us to control for physical health status of patients which is an important 
determinant of depression. 
 
4.4 Conclusions 
The findings of the present study indicate high depression prevalence in patients on ART in rural 
South Africa and the need to address it in ART programmes. Specifically, our results demonstrate 
that instrumental social support but not emotional social support affects depression in HIV-
positive patients on ART in rural South Africa. The availability and accessibility of instrumental 
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social support would therefore play a critical role in protecting HIV positive patients on ART.   
Further, two (2)  among the six strategies to cope with HIV/AIDS infections (“avoid being with 
people generally” and “ try to keep it(HIV/AIDS) from bothering you”)  were found to be 
significantly associated with depression among patients on ART. Whereas “avoid being with 
people generally” was found to be positively associated with depression, “try to keep it from 
bothering you” was negatively associated with depression. Our findings are consistent with other 
studies which found social support to be associated with depression in HIV patients.(76, 77, 86, 87)  
Socio-economic status was (SES) also associated with depression but the effect becomes 
insignificant when we adjusted for social support. The reasons are not known in this study but the 
causal pathway may likely be through social support.  Higher CD4 cell count (>200) was found to 
significantly  associated with low depression prevalence and these results are similar to a study by 
Robbins et al who found that changes in CD4 count affect psychological distress. There was no 
significant difference in prevalence of depression among patients by gender. 
In addition to drug treatment, interventions improving instrumental social support (or substitutes 
for such support) and changes in two particular strategies to cope with HIV infection may be 
effective in reducing this disease burden among ART patients. 
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Appendix 1: Prevalence of depression among patients on ART by GHQ scoring methods
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Appendix 2: Multivariate logistic regression analysis of factors associated with depression in 
patients on ART 
            Variable                                   OR   (95% CI)*                   
Gender 
        Male 
        Female 
Age (years)                                                                                             
Marital Status 
        Single 
        Married 
        Cohabiting 
Highest Education 
        None 
        Primary 
        Secondary 
        Matric/higher 
SES                                                                     
Social Support (instrumental)                    
Copping Strategies 
 Avoided being with people in general 
Tried to keep it from bothering you 
CD4 cell count 
       <=200 
         >200 
                                    
                                             1 
                                   0.99 (0.39 – 2.51)                      
1.00 (0.96 – 1.05) 
 
                               1 
                                   1.53 (0.62 – 3.76) 
                                   1.88 (0.43 – 8.23) 
 
                                               1 
1.55(0.48 – 4.99) 
0.95 (0.29 – 3.16) 
                                   0.75 (0.16 – 3.50) 
                            0.86 (0.72 – 1.03)                         
                             0.69 (0.54 – 0.87)**                             
 
                                    2.83 (1.37 – 5.88)**                   
                                    0.53 (0.24 – 1.16)                       
 
                                          1                                                 
                              0.40 (0.19 – 0.83)*                                                                                                               
                                                                                                                                               
Note:  *P< 0.05   **P< 0.01    ***P< 0.001                        All factors adjusted for each other 
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Appendix 3: 12 item version of the General Health Questionnaire (GHQ12) 
Name Date 
Please consider the last four weeks and answer the following questions by selecting and 
circling one of the four answer options. 
Question 1 2 3 4 
1. Been able to concentrate on    
what you’re doing 
Better than 
usual 
Same as 
usual 
Less than 
usual 
Much less 
than usual 
2. Lost much sleep over worry Not at all No more 
than usual 
Rather more 
than usual 
Much more 
than usual 
3. Felt you were playing a useful 
part in things 
More so than 
usual 
Same as 
usual 
Less useful 
than usual 
Much less 
useful 
4. Felt capable of making 
decisions about things 
More so than 
usual 
Same as 
usual 
Less useful 
than usual 
Much less 
useful 
5. Felt constantly under strain Not at all No more 
than usual 
Rather more 
than usual 
Much more 
than usual 
6. Felt you couldn’t overcome 
your difficulties 
Not at all No more 
than usual 
Rather more 
than usual 
Much more 
than usual 
7. Been able to enjoy your 
normal day-to-day activities 
More so than 
usual 
Same as 
usual 
Less useful 
than usual 
Much less 
useful 
8. Been able to face up to your 
problems 
More so than 
usual 
Same as 
usual 
Less useful 
than usual 
Much less 
useful 
9. Been feeling unhappy and 
depressed 
Not at all No more 
than usual 
Rather more 
than usual 
Much more 
than usual 
10. Been losing confidence in    
yourself 
Not at all No more 
than usual 
Rather more 
than usual 
Much more 
than usual 
11. Been thinking of yourself as 
a worthless person. 
Not at all No more 
than usual 
Rather more 
than usual 
Much more 
than usual 
12. Been feeling reasonably 
happy, all things considered 
More so than 
usual 
About the 
same as 
usual 
Less so than 
usual 
Much less 
than usual 
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Appendix 4: GHQ12 questions and scoring methods 
Positive worded questions scored 0 0 1 1 on both GHQ and CGHQ scoring methods but scored 0 1 2 3 on 
the Likert scoring method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Negative worded questions scored 0 0 1 1 on GHQ method, 0 1 1 1 on CGHQ method and scored 0 1 2 3 
     on the Likert scoring method                                           
 
 
 
 
 
 
GHQ 
Positive 
items 
GHQ01 GHQ03 GHQ04 GHQ07 GHQ08 GHQ12 
GHQ 
Negative 
items 
GHQ05 GHQ06 GHQ09 GHQ10 GHQ11 
 
GHQ02 
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Appendix 5: Adherence Study Questionnaire 
 
  
Study ID:______________ 
Interviewer code: ____________ 
Date Interview conducted: _____ _____/_____ _____/ _____ _____ 
    D      D        M        M       Y         Y 
 
 
 
 
 
 
 
Review by interviewer: ______ 
Reviewed by second RA: _________ 
Data entered: _________(date: _____/_____/_______) 
QC completed: __________ 
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ADHERENCE STUDY QUESTIONNAIRE: INTERVIEW 
I would first like to ask you some questions about your antiretroviral 
treatment. 
 
1.  (Please indicate the sex of the respondent. Circle one.) 
  Female ……………………………… 1 
 Male ………..………..........................2 
 
2.  When is your birthday?  
 DAY:                  MONTH:                      YEAR: 19   
 
3.   For how many months have you been taking antiretroviral  
 medication? 
  MONTHS:    
 
4.  Have you told anyone that you are HIV positive?   
  (Circle one.) 
  Yes (Ask Q. 5)……………………… 1 
  No (Skip to Q. 6)………..………...... 2 
  No reply ……………………………...99  
 
5.  Could you tell me who you have told that you are HIV   
  positive? (Read categories to respondent and circle answer  
  for yes or no to each.) 
   Yes No No 
reply 
  a.  Father ……………………………. 1 2 3 
  b.  Mother…………………………… 1 2 3 
  c.  Partner…………………………… 1 2 3 
  d.  Sister ………….............................. 1 2 3 
7.  Could you tell me who you have told that you are currently  
  taking antiretroviral medication? (Read categories to 
  respondent and circle answer for yes or no to each.) 
   Yes No No 
reply 
  a.  Father ………………………….. 1 2 3 
  b.  Mother…………………………. 1 2 3 
  c.  Partner………………………….. 1 2 3 
  d.  Sister …………........................... 1 2 3 
  e.  Brother…………………………. 1 2 3 
  f.  Aunt ..…………........................... 1 2 3 
  g.  Uncle…………………………… 1 2 3 
  h. Grandmother ….............................1 2 3 
  i.  Grandfather………………………1 2 3 
  j.  Friend………................................ 1 2 3 
  k.  Son ..………….............................1 2 3 
  l.  Daughter..…………..................... 1 2 3 
  m.  Other (Specify.) ______________ 
 
8. Could you tell me whether you take any of the following?  
 (Read categories to respondent and circle answer for yes or  
 no to each.) 
   Yes No No 
reply 
 a.  Herbal medicine ……………….. 1 2 3 
 b.  Nutrition (vitamins, oils, etc.)….. 1 2 3 
 c.  Anti-AIDS muti…....................... 1 2 3 
 d.  Other (Specify.) ______________ 
 
In order to treat diseases or conditions other than HIV/AIDS are you 
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  e.  Brother…………………………… 1 2 3 
  f.  Aunt ..…………............................. 1 2 3 
  g.  Uncle…………………………….. 1 2 3 
  h. Grandmother ….............................. 1 2 3 
  i.  Grandfather………………………. 1 2 3 
  j.  Friend……….................................. 1 2 3 
  k.  Son ..…………...............................1 2 3 
  l.  Daughter..…………........................ 1 2 3 
  m.  Other (Specify.) ______________ 
 
6.  Have you told anyone that you are taking antiretroviral   
  medication? (Circle one.) 
  Yes (Ask Q. 7)……………………… 1 
  No (Skip to Q. 8)………..………...... 2 
  No reply ……………………………...99  
 
 
 
 
 
 
 
 
 
 
12.  Would you tell me why you have put off going to the clinic or  
  the hospital in the last 3 months? (Read categories to   
  respondent and circle answer for yes or no to each.) 
     Yes No No 
reply 
currently going to any of the following? Yes No No 
reply 
 a.  Inyanga………….……………… 1 2 3 
 b.  Sangoma……………………….. 1 2 3 
 c.  Umthandazi …………................. 1 2 3 
 d.  Kwamsane clinic……………….. 1 2 3 
 e.  Another government clinic…….. 1 2 3 
 f.  Hlabisa hospital ………………... 1 2 3 
 g.  Another government hospital …. 1 2 3 
 h.  Private clinic or hospital ..……... 1 2 3 
 i.  Pharmacy……………………….. 1 2 3 
 j.  Self-treatment …………...............1 2 3 
 k.  Other (Specify.) ______________ 
 
10.   How long does it usually take you to travel from your home to  
 Kwamsane clinic? 
  MINUTES:   
 
11.  In the last 3 months, have you ever put off going to the clinic or
 or  
hospital? (Circle one.) 
  Yes (Ask Q. 12)………………….. 1 
  No (Skip to Q. 13)……..………... 2 
 No reply …………………………….99 
 
 
 
14.  Would you say that you have set times for getting up and going  
to bed? (Circle one.) 
  Yes………………………………… 1 
  
0708083F     
61 
   a.  I was too sick……………………1 2 3 
   b.  I didn’t have enough money  
       to pay for transport to get there…1 2 3 
   c.  Transport was unavailable............1 2 3 
   e.  I had family obligations................1 2 3 
   f.  I did not have anyone to  
        accompany me..............................1 2 3 
   g.  Taking care of someone else   
        was more important to me........... 1 2 3 
   h.  I had to work…………................1 2 3 
   i.  Other (Specify.) ______________ 
 
I would now like to ask you two questions about your daily life. 
13.  Would you say that you have regular routines every day?   
(Circle one.) 
  Yes ………………………………... 1 
  No ……..……….............................. 2 
 No reply …………………………….99 
  
  No………………….…..………...... 2 
 No reply …………………………….99 
 
15.  Overall, how would you rate the quality of the care you 
 received in this antiretroviral clinic in the last month? (Circle  
 one.) 
  Poor………………………………... 1 
 Fair………………………………… 2 
 Good………………………………. 3 
 Very good…………………………..4 
 Excellent……………………………5 
 No reply …………………………….99 
16.   These next questions are about your overall health and quality of life. Overall, how would you rate your current health? (Show to  
 respondent and ask him/her to circle one number) 
 
|_______|_______|_______|______|_______|_______|_______|______|_______|_______| 
0 1 2 3 4 5 6 7 8 9 10 
Worst                      Halfway     Best  
possible                           between  possible 
health                      worst and best  health 
17.   Overall, how would you rate your quality of life? (Show to the respondent and ask him/her to circle one number) 
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|_______|_______|_______|______|_______|_______|_______|______|_______|_______| 
0 1 2 3 4 5 6 7 8 9 10 
Worst                      Halfway     Best  
possible                           between  possible 
quality                       worst and best  quality 
of life   of life 
 
Like most people, it is likely that you have missed taking your antiretroviral medication at some point in time.  In order to improve the 
adherence support that patients are getting, we would like to ask you three questions about how often you have missed taking  your 
antiretroviral pills.  Because you take the antiretroviral pills two times every day, there are two possibilities each day when you could have 
missed taking your antiretroviral pills.  We ask you to answer the questionnaire with only your ANTIRETROVIRAL medication in mind, i.e. 
the mediation in the seven-day pill boxes that you receive from the antiretroviral treatment services.   
 
18.  During the last 7 days, how many times, in total, did you miss taking one or more of your antiretroviral pills?  
            times 
 
19. During the last 7 days, how many times, in total, did you take one or more of your antiretroviral pills more than two hours late?  
            times 
 
 
 
20.  How would you rate your adherence over the last month? (Circle one.) 
  Very poor………………………….. 1 
 Poor………………………………... 2 
 Fair………………………………… 3 
 Good………………………………. 4 
 Very good…………………………. 5 
Excellent……………………………6 
 No reply ……………………………99 
 
21.  Please put a cross on the line below at the point showing your best guess about how many antiretroviral pills you have taken in the  last 
month.  We would be surprised if this is 100% for most people, e.g. 0% means you have taken none of the pills; 50% means you  have taken 
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half your pills; 100% means you have taken every single pill. (Hand instrument and pen to respondent.) 
 
|_______|_______|_______|______|_______|_______|_______|______|_______|_______| 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
None                       Half    All  
 
22.  When was the last time that you missed taking your antiretroviral pills? 
 Today …………………………………………….........……………………………………… 1 
 Yesterday….………………………………………………………. …………………………. 2 
 Earlier this week ………………………………………….………. …………………………. 3 
 Last week …………………………………………………………. …………………………. 4 
 Less than a month ago…………………………………………….. …………………………. 5 
 More than a month ago …………………………………………… …………………………. 6 
 I have never missed ..…………………………………………………………………………. 7 
 No reply ………………………………………………………………………………………. 99 
 
23.   Would you tell me why you missed taking your antiretroviral pills?  Please only think about the last time that you missed taking your  
 antiretroviral pills. (Now check all that apply) 
 You felt too sick………………………………………………………………………………..1 
 You did not have the pills with you…………………………………………………………… 2 
 You forgot to take them……………………………………………………………………….. 3 
 You had run out of pills……………………………………………………………………….. 4 
 You were afraid to lose your government disability grant……………………………………. 5 
 You were too busy to take the pills…………………………………………………………….6 
 You were afraid that someone would see you take them………………………………………7 
 You did not want to…………………………………………………………………………… 8 
 You wanted to avoid side effects……………………………………………………………… 9 
 A doctor, nurse or treatment counselor has told you to stop………………………………….. 10 
 Someone other than your doctor, nurse or treatment counselor told you to stop…………….. 11   
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 Other (Specify)_________________ 
 
24. In the past 3 months have you had any side effects which you think may have been a result of taking your antiretroviral pills.   
 These may include nausea, diarrhea, skin rashes or pain in your feet. 
  Yes ………………………………...1 
  No ……..………..............................2 
 No reply ……………………………99 
 
25.  If yes, check all that apply (if no skip to Q.26) 
 Diarrhea or nausea………………….1  
 Rash or itching…………………….. 2 
 Pain in your hands and feet……….. 3 
 Feeling tired……………………….. 4 
 Change of body shape …………….. 5 
 Other (Specify)_________________ 
 
26. In response to having HIV infection, how often during the past four weeks have you done each of the following? Would you say all  of 
the time, most of the time, some of the time or none of the time? (Read categories to respondent and circle one number on each    
 line.) 
   All of the Most of Some of
 None of   
   time  the time the time the 
time 
 Avoided being with people in general.............................................. 1 2 3 4 
 Kept yourself from thinking too much about AIDS......................... 1 2 3 4 
 Asked other people for advice and information................................ 1 2 3 4 
 Talked to someone about how you were feeling about  
 having HIV....................................................................................... 1 2 3 4 
 Tried to keep it from bothering you................................................. 1 2 3 4 
 Involved yourself in volunteer work or an AIDS community  
 organization (e.g. helping others with HIV or AIDS)...................... 1 2 3 4 
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27. Now, I would like to ask you some questions about the support you receive from others in your daily life.  We are interested in the 
 support you receive in all aspects of your daily life, not only with regards to taking your antiretroviral pills.      
   As much as Less than Much less than
 Never  
   I would like  I would like I would like  
 I get visits from friends and relatives............................................... 1 2 3 4 
 I get useful advice about important things in my life....................... 1 2 3 4 
 I get chances to talk to someone about problems at work  
 or with my housework.?................................................................... 1 2 3 4 
 I have opportunities to talk to someone I trust about my personal  
 life and about family problems......................................................... 1 2 3 4 
 I get help with child care….............................................................. 1 2 3 4 
 I have people who care what happens to me.................................... 1 2 3 4 
 I get love and affection…................................................................. 1 2 3 4 
 I get help around the house…........................................................... 1 2 3 4 
 I get help with money in an emergency…........................................ 1 2 3 4 
 I get help when I need transport………........................................... 1 2 3 4 
 I get help when I am sick….............................................................. 1 2 3 4 
 
28. Please consider the last four weeks and answer the following questions by selecting and circling one of the four answer options. 
 Have you … (Circle one in each line.) 
        Better than  Same as Less than 
 Much less  
   usual  usual usual than 
usual 
 Been able to concentrate on what you’re doing................................ 1 2  3 4 
   Not at all No more Rather more
 Much more 
     than usual than usual than 
usual 
 Lost much sleep over worry............................................................. 1 2  3 4 
   More so Same as Less than
 Much less 
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   than usual usual usual than 
usual 
 Felt you were playing a useful part in things.................................... 1 2  3 4 
 Felt capable of making decisions about things……………………. 1 2  3 4 
    Not at all No more  Rather more
 Much more 
     than usual  than usual than 
usual 
 Felt constantly under strain……………………………………….. 1 2  3 4 
 Felt you couldn’t overcome your difficulties................................... 1 2  3 4 
   More so Same as  Less than
 Much less 
   than usual usual  usual than 
usual 
 Been able to enjoy your normal day-to-day activities...................... 1 2  3 4 
 Been able to face up to your difficulties..........................................  1 2  3 4 
 (Continued on the next page.) 
   Not at all No more  Rather more
 Much more 
     than usual  than usual than 
usual 
 Been feeling unhappy and depressed…………............................... 1 2  3 4 
 Been losing confidence in yourself………….................................. 1 2  3 4 
 Been thinking of yourself as a worthless person……….................. 1 2  3 4 
   More so Same as  Less than
 Much less 
   than usual usual  usual than 
usual 
 Been feeling reasonably happy all things considered…................... 1 2  3 4 
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The next questions are about items that your household owns. 
29.  Does your household own the following items? (Circle  
“yes” if respondent’s household owns item.) 
     Yes No No 
reply 
 a. Telephone……………………. 1 2 3 
 b. Cell phone…………………… 1 2 3 
 c.  Watch …………...................... 1 2 3 
 d.  Alarm clock………………….. 1 2 3 
 e.  Radio/stereo……… ..……....... 1 2 3 
 f.   Primus cooker, sikeni……....... 1 2 3 
 g.  Electric hot plate....................... 1 2 3 
 h.  Electric stove plate…………... 1 2 3 
 i.   Gas cooker …………............... 1 2 3 
 j.   Fridge/freezer………………... 1 2  3 
 b.  Electric kettle………………... 1 2 3 
 c.  Television set ………….......... 1 2 3 
 d.  Video cassette recorder……… 1 2 3 
 e.  Block maker…………………. 1 2 3 
 f.  Sewing machine……………… 1 2 3 
 g.  Car or bakkie……………........ 1 2 3 
 h.  Motorcycle or scooter……….. 1 2 3 
 i.   Bicycle ………….................... 1 2 3 
 j.  Kombi/lorry/tractor………….. 1 2 3 
 k.  Table/chairs……… ..…........... 1 2 3 
 l.   Sofa/sofa set…………............. 1 2 3 
 m. Kitchen sink............................. 1 2 3 
 n.  Car battery for electricity……. 1 2 3 
 o.  Wheelbarrow …………........... 1 2 3 
 p.  Hoe, spade or garden fork…… 1 2  3 
31.  Have you had a meal last night? (Circle  
 one.) 
 Yes ……………………………….. 1 
 No …………………..……………. 2 
 No reply …………………………... 99 
 
32. Have you had a meal this morning? (Circle one.) 
 Yes ……………………………….. 1 
 No …………………..……………. 2 
 No reply …………………………... 99 
 
33. Do you currently receive a disability grant for HIV/AIDS?  
(Circle one.) 
 Yes (Ask Q. 34)…………………… 1 
 No (Skip to Q. 36)……..……………2  
 No reply (Skip to Q. 36)……………..99 
 
34.  Since when have you been receiving the disability grant 
for  HIV/.AIDS? 
 
DAY:                    MONTH:                       YEAR: 20 
 
 
35.  From which government welfare office are you receiving 
the  HIV disability grant? 
 
                                                  (PLEASE WRITE NAME) 
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 q.  Bed nets……………………… 1 2 3 
 r.   Cattle …………....................... 1 2 3 
 s.  Other livestock……………….. 1 2 3 
 
30. Has there ever been a time when the household was buying  
 something on hire-purchase or lay by and could not make the  
 payment and the good was re-possessed or you lost the money 
 you had paid? (Circle one.) 
 Yes………………………………… 1 
 No….…..…….................................. 2 
  No reply ………………………….. 99 
 
36.  During the past 4 weeks, on how many days did you have 
a  drink containing alcohol (such as a can of beer, a glass of 
Zulu  beer, a glass of whine, a shot of hard liquor)? 
 NUMBER OF DAYS: 
 
 
Thank you very much for your help! 
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Appendix 6: Map showing the location of the study area 
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Appendix 7: University of Witwatersrand Human Research Ethics committee’s Approval 
Letter 
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Appendix 8: University of KwaZulu-Natal Biomedical Research Ethics Approval Letter 
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Appendix 9: Letter of permission for use of data from Africa Centre for Health and 
Population Studies 
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